These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15808755)

  • 1. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
    Hopkins PN; Wu LL; Hunt SC; Brinton EA
    J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
    Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
    Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients.
    Tseng CH; Tseng CP; Chong CK; Cheng JC; Tai TY
    Int J Cardiol; 2006 Jul; 111(1):80-5. PubMed ID: 16213608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid profiles with and without CAD: Jordan Hyperlipidaemia and Related Targets Study (JoHARTS-1).
    Hammoudeh AJ; Izraiq M; Al-Mousa E; Al-Tarawneh H; Elharassis A; Mahadeen Z; Badran N; Haddad J
    East Mediterr Health J; 2008; 14(1):24-32. PubMed ID: 18557449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
    Barbagallo CM; Rizzo M; Noto D; Frasheri A; Pernice V; Rubino A; Pieri D; Pinto V; Cefalù AB; Giordano C; Notarbartolo A; Averna MR
    Metabolism; 2006 May; 55(5):662-8. PubMed ID: 16631444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between androgen levels and premature coronary artery disease in men.
    Turhan S; Tulunay C; Güleç S; Ozdöl C; Kilickap M; Altin T; Gerede M; Erol C
    Coron Artery Dis; 2007 May; 18(3):159-62. PubMed ID: 17429287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?
    Iribarren C; Go AS; Husson G; Sidney S; Fair JM; Quertermous T; Hlatky MA; Fortmann SP
    J Am Coll Cardiol; 2006 Nov; 48(9):1800-7. PubMed ID: 17084253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of major modifiable risk factors among patients with coronary artery disease--a retrospective analysis.
    Achari V; Thakur AK
    J Assoc Physicians India; 2004 Feb; 52():103-8. PubMed ID: 15656042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.
    Hopkins PN; Nanjee MN; Wu LL; McGinty MG; Brinton EA; Hunt SC; Anderson JL
    Atherosclerosis; 2009 Dec; 207(2):559-66. PubMed ID: 19524242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
    Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
    Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the metabolic syndrome and newly diagnosed coronary artery disease.
    Baltali M; Gokcel A; Kiziltan HT; Korkmaz ME; Topcu S; Yalcin F; Demircan S; Yigit F; Ozin B; Muderrisoglu IH
    Diabetes Nutr Metab; 2003 Jun; 16(3):169-75. PubMed ID: 14635734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.